FDA Adverse Event Other Summary report: N

OMNIPOD INSULIN PUMP

MDR report key: 1914117 · Received November 24, 2010

Report

Report Number
3004464228-2010-01401
Event Type
Other
Date Received
November 24, 2010
Date of Event
October 28, 2010
Report Date
October 28, 2010
Manufacturer
INSULET CORPORATION
Product Code
LZG
PMA / PMN Number
K042792
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

THE CUSTOMER REPORTED THAT THE CANNULA HAD DEPLOYED 45 MINUTES AFTER THE POD WAS FIRST APPLIED. THIS INDICATES THAT THE NEEDLE MECHANISM POSSIBLY MALFUNCTIONED DUE TO A DAMAGED COMPONENT. SINCE THE POD WAS NOT RETURNED FOR EVAL, HOWEVER, NO MALFUNCTION CAN BE CONFIRMED. THE OMNIPOD USER GUIDE INSTRUCTS USERS TO "CHECK THE INFUSION SITE AFTER INSERTION" TO ENSURE THAT THE CANNULA IS SEATED PROPERLY. IF LABELING INSTRUCTIONS WERE PROPERLY FOLLOWED, THE USER WOULD HAVE NOTICED THAT THE CANNULA HAD NOT FIRED AND WOULD HAVE IMMEDIATELY DEACTIVATED THE DEVICE. DESPITE THE CANNULA REPORTEDLY FIRING 45 MINUTES AFTER THE POD WAS APPLIED, THE CUSTOMER PROCEEDED TO WEAR THE DEVICE OVERNIGHT. THE DEVICE WAS NOT REMOVED UNTIL THE NEXT MORNING, AFTER THE CUSTOMER EXPERIENCED HIGH BG READINGS. THE USER GUIDE ALSO ADVISES USERS TO CHECK THEIR BLOOD GLUCOSE LEVELS FREQUENTLY SO THEY'RE ABLE TO REACT QUICKLY AND APPROPRIATELY TO ANY ISSUES.

Description of Event or Problem · 1

THE CUSTOMER REPORTED THAT SHE NEITHER HEARD NOR FELT THE CANNULA INSERT WHEN A NEW POD WAS APPLIED; SHE "JUST ASSUMED THAT IT WAS IN ALREADY". FORTY-FIVE MINUTES LATER, SHE "FELT THE CANNULA DEPLOY INTO HER SKIN." DESPITE THE DELAYED DEPLOYMENT OF THE CANNULA, SHE PROCEEDED TO WEAR THE POD OVERNIGHT. SHE WOKE UP IN THE MORNING WITH A HIGH BG READING OF 375 MG/DL AND DECIDED TO REMOVE THE POD. THE DEVICE WILL BE RETURNED FOR EVAL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 OMNIPOD INSULIN PUMP PUMP, INFUSION, INSULIN LZG INSULET CORPORATION 11200 L30327

Patients

Seq Age Sex Outcome Treatment
1 69 YR Other